OTC · Financial Statements

Lexington Biosciences, Inc. (LXGTF) Financial Statements

$0.00 OTC: LXGTF Market Cap $379

Lexington Biosciences, Inc. most recently reported annual revenue of $0, net profit of $0. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric20192020202120222023
Revenue$0$0$0$0$0
Operating Profit$-1.0M$0$0$0$0
Net Profit$-1.0M$0$0$0$0
EPS$-0.34$0.00$-0.01$-0.01$-0.01
Op Margin—————

Balance Sheet (USD)

Metric20192020202120222023
Total Assets$0$0$0$0$0
Total Liabilities$1.0M$2.0M$2.0M$1.0M$1.0M
Cash$0$0$0$0$0
Borrowings$1.0M$0$0$0$0

Cash Flow (USD)

Metric20192020202120222023
Operating Cash Flow$0$0$0$0$0
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$0$0$0$0$0
Free Cash Flow$0$0$0$0$0

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA0.00
FCF Yield0.00%
Quick Ratio0.00
Interest Coverage0.00
Return 1Y0.00%
Return 3Y0.00%
Return 5Y—

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
LXGTF Overview LXGTF Dividend Run Stock Screener